ModernMedicine Resource Center More Topics


[BLOG]: Hepatitis C market competition arrives for 2015There is plenty of activity already in the hepatitis C market as competition has arrived for 2015, including CVS Health versus Express Scripts and Gilead Sciences versus AbbVie, over FDA-approved hepatitis C treatments. This will have implications for retail prescriptions as well as continuity-of-care programs within non-Medicare accountable care organizations (ACOs) and health systems.
FDA concerned about generic ADHD drugsFDA has warned about 2 approved generic versions of Concerta tablets to treat attention-deficit hyperactivity disorder (ADHD).
FDA questions effectiveness of two generic versions of ConcertaFDA recently raised concerns that two generic versions of Concerta (methylphenidate hydrochloride extended-release tablets; Janssen Pharmaceuticals) may not be therapeutically equivalent to the brand-name drug.
Senate hearing will explore soaring prices of generic drugsA Senate panel is scheduled to hold a hearing on November 20, 2014, to investigate why the prices of some generic drugs are skyrocketing.
Camber PharmaceuticalsCamber Pharmaceuticals strives to be the most reliable and cost effective generic pharmaceutical supplier across a broad range of therapeutic classes.
Lupin Pharmaceuticals, Inc. committed to quality, innovation
GREENSTONE LLC is one of the longest-running U.S. marketers of generics
5 ways to reduce costs and keep patients healthyPrice continues to drive prescription drug trend
Keep specialty and generic drug pricing on your radarOptimize benefit plans to motivate patients to take advantage of cost-effective drugs
CVS Caremark and Cardinal Health team up to supply generic drugsThe two companies have signed an agreement that commits them to a “50/50 joint venture” that may dominate the US market.